Thirona, founded in 2014 by Eva van Rikxoort and based in Nijmegen, Netherlands, develops high-precision AI analysis for thoracic CT images. It offers expertise-based services and AI-powered lung image analysis to MedTech, pharmaceutical, and CRO companies. Thirona partners with research institutions and medical companies on innovation programs aimed at enabling breakthroughs in precision medicine for pulmonary diseases. The company’s stated mission is to apply domain knowledge and artificial intelligence to make personalized treatments for lung diseases more accessible. Thirona recently secured €7.5M in funding to support efforts to advance precision medicine and enhance patient care for lung diseases. Its software category is AI-powered medical image analysis and its website is thirona.eu. Thirona builds computer algorithms for medical image analysis, concentrating on lung CT scans. The company is a Radboud University medical spin-off founded in 2014 by Eva van Rikxoort and Bram van Ginneken. Its work aims to improve diagnostic speed and accuracy and to reduce physicians' workload through AI-assisted image analysis. Thirona is participating in collaborative projects to extend its algorithm development into oncology imaging. The company is working alongside clinical and industry partners to integrate imaging into precision‑medicine workflows. The article does not disclose revenue, users, or other financial metrics.

Total raised

$10M

Funding rounds

3

Latest round

Equity

Latest activity

Sep 2023